Article

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers

2021-03-23

Abstract excerpt

As the COVID-19 pandemic continues to spread, hundreds of new initiatives including studies on existing medicines are running to fight the disease. To deliver a potentially immediate and lasting treatment to current and emerging SARS-CoV-2 variants, new collaborations and ways of sharing are required to create as many paths forward as possible. Here we leverage our expertise in computational antibody engineering t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 888c4f5e-041a-573b-91ba-76a2c1fc64ab
DOI: 10.1101/2021.03.23.436613

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizersDOI 10.1101/2021.03.23.436613Read

Rapid <i>in silico</i> design of antibodies targeting SARS-CoV-2 using machine learning and supercomputingSemantic proximity Read

Antibody drugs targeting SARS-CoV-2: Time for a rethink?Semantic proximity Read

Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2Semantic proximity Read

Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolutionSemantic proximity Read

Broad Neutralizing Antibodies Against SARS-CoV-2: Current Progress and Engineering Strategies.Semantic proximity Read

Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escapeSemantic proximity Read

Fast Restoration of a Broad-Spectrum SARS-Cov Therapeutic Antibody for SARS-Cov-2Semantic proximity Read

Development of an Escape-resistant SARS CoV-2 Neutralizing Synthetic NanobodySemantic proximity Read

In silico evaluation of ten monoclonal antibodies neutralization power of SARS-CoV-2 variants EG.5, BA.2.86 and JN.1Semantic proximity Read

In Silico Evaluation of Ten Monoclonal Antibodies Neutralization Power of SARS-CoV-2 Variants EG.5, BA.2.86 and JN.1Semantic proximity Read

Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library ScreeningSemantic proximity Read

Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.Semantic proximity Read